• We are a biotech company in
    infectious diseases with
    two marketed products.

  • Dedicated to innovation in
    vaccine research & development.

  • Valneva covers the full
    value chain from bench
    to market.


Welcome to Valneva

A leading pure play vaccine biotech company.


— July 23, 2015

Valneva and PaxVax Enter into Marketing and Distribution Agreement

Read more

— Stock information



—News, June 22, 2015

Valneva takes direct control over Marketing and Distribution of IXIARO® to increase margin and profitability

 Read more

— Financial calendar

Half-Year Results 2015  
August 31, 2015

Q3 Results 2015
November 10, 2015

All dates     


play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs

Boston, U.S.
15-17 September, 2015

Munich, Germany
2–4 November, 2015 

World Vaccine Congress Europe
Madrid, Spain
9-11 November 2015

Jefferies Autumn 2015 Global Healthcare Conference London, UK
18-19 November, 2015


European pure vaccine player with international footprint.

Please update your browser...